Olr769 Activators
Chemical activators of Olr769 can initiate a variety of intracellular signaling cascades that ultimately result in the protein's activation. Forskolin, by directly stimulating adenylyl cyclase, increases cAMP levels within the cell, which in turn activates protein kinases dependent on this second messenger. These kinases can phosphorylate Olr769, leading to its activation. Similarly, PMA, as an activator of protein kinase C (PKC), initiates a phosphorylation cascade where PKC or downstream kinases in the PKC pathway might phosphorylate and activate Olr769. Ionomycin, by increasing intracellular calcium, activates calcium-dependent kinases that could be responsible for the phosphorylation and activation of Olr769. BAY K8644, which targets L-type calcium channels, also increases intracellular calcium, potentially triggering the activation of Olr769 through similar calcium-mediated signaling pathways.
In addition to these, agents such as Thapsigargin, which disrupt calcium homeostasis by inhibiting the SERCA pump, can lead to the activation of Olr769 through calcium-dependent signaling mechanisms. Ouabain disrupts ionic gradients by inhibiting the Na⁺/K⁺-ATPase, which could indirectly lead to the activation of signaling pathways involving Olr769. Zinc pyrithione increases intracellular zinc concentration, which can serve as a cofactor for kinases that phosphorylate Olr769. Veratridine's action on sodium channels can cause cellular depolarization, potentially leading to the activation of Olr769 as part of the subsequent signaling response. Anisomycin, which activates SAPKs such as JNK, can promote the phosphorylation of Olr769 if it is part of the stress-activated signaling pathways. Inhibitors of protein phosphatases, such as Okadaic Acid and Calyculin A, prevent the dephosphorylation of proteins, which could include Olr769, leading to its active state. Lastly, the use of H-89, a PKA inhibitor, can initiate a compensatory activation of other kinases that may target and activate Olr769.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC) which can phosphorylate numerous substrates within the cell. PKC-mediated phosphorylation can lead to the activation of Olr769 if Olr769 is a substrate for PKC or if PKC phosphorylates upstream regulators that control Olr769 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore that selectively binds to and transports calcium ions across cell membranes, thereby increasing intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases that may phosphorylate and activate Olr769, given that Olr769 is part of calcium signaling pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
BAY K8644 functions as a calcium channel agonist, specifically activating L-type calcium channels. This agonistic action results in increased calcium influx and the subsequent activation of calcium-dependent kinases. These kinases can phosphorylate and activate Olr769 if Olr769 activity is regulated by calcium-dependent signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium concentration. This increase can activate Olr769 through the activation of calcium-dependent kinases if Olr769 is part of the calcium-regulated signaling pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a specific inhibitor of the Na⁺/K⁺-ATPase pump which can lead to changes in intracellular ionic concentrations and secondary activation of signal transduction pathways that may include Olr769 activation as Na⁺/K⁺-ATPase pump activity can influence cellular signaling cascades that activate Olr769. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc pyrithione facilitates the increase of intracellular zinc levels, which can act as a cofactor for various enzymes, including kinases that may have Olr769 as a substrate or that can phosphorylate proteins upstream of Olr769 leading to its activation. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $82.00 $104.00 $201.00 $379.00 | 3 | |
Veratridine binds to and activates voltage-gated sodium channels, which can cause depolarization of the cell membrane. This depolarization can trigger a cascade of intracellular events that activate signaling pathways involving Olr769, leading to its activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs) like JNK. Activation of these kinases can lead to the activation of Olr769 through phosphorylation if Olr769 is involved in the stress-activated signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid acts as a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases leads to an increased phosphorylation state of proteins, which could include the activation of Olr769 if the phosphatases normally regulate the phosphorylation state of Olr769, maintaining it in an inactive state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like Okadaic Acid, is an inhibitor of protein phosphatases, particularly PP1 and PP2A. This leads to a hyperphosphorylated state within the cell that could result in the activation of Olr769, assuming that dephosphorylation by these phosphatases normally keeps Olr769 in an inactive state. | ||||||